Cargando…
Description and validation of a Markov model of survival for individuals free of cardiovascular disease that uses Framingham risk factors
BACKGROUND: Estimation of cardiovascular disease risk is increasingly used to inform decisions on interventions, such as the use of antihypertensives and statins, or to communicate the risks of smoking. Crude 10-year cardiovascular disease risk risks may not give a realistic view of the likely impac...
Autores principales: | Martin, Chris, Vanderpump, Mark, French, Joyce |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC434521/ https://www.ncbi.nlm.nih.gov/pubmed/15157279 http://dx.doi.org/10.1186/1472-6947-4-6 |
Ejemplares similares
-
Validation and recalibration of the Framingham cardiovascular disease risk models in an Australian Indigenous cohort
por: Hua, Xinyang, et al.
Publicado: (2017) -
Framingham cardiovascular risk in patients with obesity and periodontitis
por: Pires, Juliana Rico, et al.
Publicado: (2014) -
Framingham Contribution to Cardiovascular Disease
por: Hajar, Rachel
Publicado: (2016) -
Framingham Risk Score with Cardiovascular Events in Chronic Kidney Disease
por: Chen, Szu-Chia, et al.
Publicado: (2013) -
The risk of cardiovascular disease following breast cancer by Framingham risk score
por: Gernaat, Sofie A. M., et al.
Publicado: (2018)